140 results
Summary of Major Trials of Steroids in Sepsis

- Vivek Moitra, MD
@vmoitra

#Steroids #Sepsis #Corticosteroids #EBM #Evidence #Trials
Summary of Major Trials ... EBM #Evidence #Trials ... #VisualAbstract
Diabetic Nephropathy - Timeline of Important Trials

Dr. Lovy Gaur https://twitter.com/drlovygaur

#Diabetic #Nephropathy #EBM #VisualAbstract #Trials #Nephrology #Timeline
Timeline of Important Trials ... Nephropathy #EBM #VisualAbstract ... #Trials #Nephrology
#VisualAbstract for #Lancet trial #CANVASR #SGLT2i #Canagliflozin

"Canagliflozin and renal outcomes in type 2 diabetes: results from
#VisualAbstract ... for #Lancet trial ... randomised clinical trials
REBEL Review 86: IV/IO Flow Rates to Gravity 

14G
16G
Cordis
18G 
I5G Humeral IO 
16G Distal Port Triple
16G Distal Port Triple ... 18G Prox Port Triple ... IVAccess #Infusion #Table
ISCHEMIA Trial - Management Algorithm for patients with Stable Angina

Stress Test -> ? +moderate or severe
ISCHEMIA Trial - ... Management Algorithm ... patients with Stable ... with the ISCHEMIA trial ... Diagnosis #Management #Algorithm
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Major Clinical Trials ... GoalDirected #Therapy #Trials ... #EBM #VisualAbstract
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical Trials ... renal outcomes trial ... inhibitors #EBM #trial ... #visualabstract ... #table #CVD #CKD
Summary table of autoimmune diseases and the specific antibody related to the disease. Visit gramproject.com for
Summary table of ... medical diagrams, tables ... #diagnosis #algorithm ... #table #autoimmune
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
A Controlled Trial ... Migraine #CGRP #VisualAbstract
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
five landmark trials ... 18539917 #EBM #VisualAbstract ... Type2 #Landmark #Trials